Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease

Abstract Conventional disease animal models have limitations on the conformity to the actual clinical situation. Disease-syndrome combination (DS) modeling may provide a more efficient strategy for biomedicine research. Disease model and DS model of renal fibrosis in chronic kidney disease were esta...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shasha Li, Peng Xu, Ling Han, Wei Mao, Yiming Wang, Guoan Luo, Nizhi Yang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/40756b0c090a4c42b1a589c4caaaa939
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:40756b0c090a4c42b1a589c4caaaa939
record_format dspace
spelling oai:doaj.org-article:40756b0c090a4c42b1a589c4caaaa9392021-12-02T15:06:12ZDisease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease10.1038/s41598-017-09311-02045-2322https://doaj.org/article/40756b0c090a4c42b1a589c4caaaa9392017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-09311-0https://doaj.org/toc/2045-2322Abstract Conventional disease animal models have limitations on the conformity to the actual clinical situation. Disease-syndrome combination (DS) modeling may provide a more efficient strategy for biomedicine research. Disease model and DS model of renal fibrosis in chronic kidney disease were established by ligating the left ureter and by ligating unilateral ureteral combined with exhaustive swimming, respectively. Serum metabolomics was conducted to evaluate disease model and DS model by using ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Potential endogenous biomarkers were identified by multivariate statistical analysis. There are no differences between two models regarding their clinical biochemistry and kidney histopathology, while metabolomics highlights their difference. It is found that abnormal sphingolipid metabolism is a common characteristic of both models, while arachidonic acid metabolism, linolenic acid metabolism and glycerophospholipid metabolism are highlighted in DS model. Metabolomics is a promising approach to evaluate experiment animal models. DS model are comparatively in more coincidence with clinical settings, and is superior to single disease model for the biomedicine research.Shasha LiPeng XuLing HanWei MaoYiming WangGuoan LuoNizhi YangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Shasha Li
Peng Xu
Ling Han
Wei Mao
Yiming Wang
Guoan Luo
Nizhi Yang
Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease
description Abstract Conventional disease animal models have limitations on the conformity to the actual clinical situation. Disease-syndrome combination (DS) modeling may provide a more efficient strategy for biomedicine research. Disease model and DS model of renal fibrosis in chronic kidney disease were established by ligating the left ureter and by ligating unilateral ureteral combined with exhaustive swimming, respectively. Serum metabolomics was conducted to evaluate disease model and DS model by using ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Potential endogenous biomarkers were identified by multivariate statistical analysis. There are no differences between two models regarding their clinical biochemistry and kidney histopathology, while metabolomics highlights their difference. It is found that abnormal sphingolipid metabolism is a common characteristic of both models, while arachidonic acid metabolism, linolenic acid metabolism and glycerophospholipid metabolism are highlighted in DS model. Metabolomics is a promising approach to evaluate experiment animal models. DS model are comparatively in more coincidence with clinical settings, and is superior to single disease model for the biomedicine research.
format article
author Shasha Li
Peng Xu
Ling Han
Wei Mao
Yiming Wang
Guoan Luo
Nizhi Yang
author_facet Shasha Li
Peng Xu
Ling Han
Wei Mao
Yiming Wang
Guoan Luo
Nizhi Yang
author_sort Shasha Li
title Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease
title_short Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease
title_full Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease
title_fullStr Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease
title_full_unstemmed Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease
title_sort disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/40756b0c090a4c42b1a589c4caaaa939
work_keys_str_mv AT shashali diseasesyndromecombinationmodelingmetabolomicstrategyforthepathogenesisofchronickidneydisease
AT pengxu diseasesyndromecombinationmodelingmetabolomicstrategyforthepathogenesisofchronickidneydisease
AT linghan diseasesyndromecombinationmodelingmetabolomicstrategyforthepathogenesisofchronickidneydisease
AT weimao diseasesyndromecombinationmodelingmetabolomicstrategyforthepathogenesisofchronickidneydisease
AT yimingwang diseasesyndromecombinationmodelingmetabolomicstrategyforthepathogenesisofchronickidneydisease
AT guoanluo diseasesyndromecombinationmodelingmetabolomicstrategyforthepathogenesisofchronickidneydisease
AT nizhiyang diseasesyndromecombinationmodelingmetabolomicstrategyforthepathogenesisofchronickidneydisease
_version_ 1718388577075724288